Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Suzanne Jaqueth Forrest, M.D.

Concepts (81)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
High-Throughput Nucleotide Sequencing5202436390.590 Why?
Information Dissemination1202411260.520 Why?
Molecular Targeted Therapy3202428110.390 Why?
Neoplasms62024221720.370 Why?
Glioma1202234550.290 Why?
Medical Oncology1201823210.260 Why?
Pediatrics1201835890.210 Why?
Brain Neoplasms1202290310.190 Why?
Mutation32024300540.170 Why?
Child122024801570.160 Why?
Muscular Atrophy, Spinal220122580.160 Why?
Proto-Oncogene Proteins c-ret120202250.150 Why?
Fibrosarcoma120203090.150 Why?
Resource Allocation120203500.150 Why?
Microtubule-Associated Proteins1202210760.140 Why?
Osteosarcoma120238970.140 Why?
Oncogenes1202212220.140 Why?
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma120203820.140 Why?
Interleukin-21202318890.130 Why?
Infant62024361930.130 Why?
Child, Preschool72024422310.130 Why?
Specimen Handling120207020.130 Why?
Neoplasm, Residual1202010080.120 Why?
Central Nervous System Neoplasms120239160.120 Why?
Antineoplastic Agents12018136420.120 Why?
Base Sequence12022124410.100 Why?
Soft Tissue Neoplasms1202011590.090 Why?
Genomics2202458210.090 Why?
Graft vs Host Disease1202330290.090 Why?
Bone Neoplasms1202325290.090 Why?
Adolescent62024883230.080 Why?
Clinical Trials as Topic1202480020.080 Why?
Infant, Newborn22024261980.070 Why?
Ovarian Neoplasms1202348780.070 Why?
Protein Kinase Inhibitors1202256720.070 Why?
Prognosis32023296290.060 Why?
Biomedical Research1202034290.060 Why?
Gene Expression Regulation, Neoplastic1202085530.060 Why?
Humans1420247615780.050 Why?
DNA Copy Number Variations1201220200.050 Why?
Survival of Motor Neuron 2 Protein22012490.050 Why?
Follow-Up Studies22020391070.050 Why?
Loss of Heterozygosity120236620.050 Why?
Oncogene Fusion12020810.040 Why?
Antineoplastic Combined Chemotherapy Protocols12020117420.040 Why?
Tissue Banks120201840.040 Why?
BRCA2 Protein120238050.040 Why?
Gene Amplification1202310890.040 Why?
Female620243926880.040 Why?
Male520243608410.040 Why?
BRCA1 Protein1202311580.030 Why?
Clinical Trials, Phase III as Topic120208570.030 Why?
Young Adult42023592540.030 Why?
Germ-Line Mutation1202318580.030 Why?
Remission Induction1202023970.030 Why?
Phenotype12012165920.030 Why?
Severity of Illness Index12012158430.030 Why?
Analysis of Variance2201262280.030 Why?
Motor Activity2201227150.020 Why?
Oncogene Proteins, Fusion1202016090.020 Why?
Gas Chromatography-Mass Spectrometry120123530.020 Why?
Prospective Studies32023544230.020 Why?
Fatty Acids, Nonesterified120123930.020 Why?
Biopsy1202067660.020 Why?
Chromatography, Liquid120129830.020 Why?
DNA Primers1201228200.020 Why?
Immunotherapy1202346510.020 Why?
Gene Dosage1201212180.020 Why?
Survival Rate12020127250.020 Why?
Amino Acids1201217180.020 Why?
Tandem Mass Spectrometry1201211880.020 Why?
Case-Control Studies22012221760.010 Why?
Randomized Controlled Trials as Topic12020102120.010 Why?
Retrospective Studies22023806460.010 Why?
Metabolomics1201216590.010 Why?
Cross-Sectional Studies22012261270.010 Why?
Pilot Projects1201286330.010 Why?
Proteomics1201238480.010 Why?
Adult220222212000.010 Why?
Gene Expression Profiling1201294200.010 Why?
Age Factors12012183980.010 Why?
Forrest's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (81)
Explore
_
Co-Authors (63)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.